Individual Stock News
1. Bilibili-W (09626.HK) completed the issuance of US$500 million in convertible preferred notes and simultaneously repurchased approximately US$100 million in Class Z ordinary shares.
2. Dekang Agriculture and Animal Husbandry (02419.HK) reported sales revenue of RMB 10.74 billion from commercial pig sales in the first eight months.
3. Didi Chuxing-PF (02559.HK): Expects public float to be restored by the end of May 2027.
4. Saijing Technology (00580.HK) plans to participate in the establishment of a joint venture to invest in high-performance TPU AI chip-related businesses.
5. Hengrui Medicine (01276.HK): The National Medical Products Administration accepted the drug marketing authorization application for Repposite Injection.
6. Jiangnan Buyi (03306.HK) released its annual results: profit attributable to shareholders was RMB 997 million, an increase of 11.7% year-on-year. 7. CSPC Pharmaceutical Group (01093.HK): Goserelin sustained-release injection (SYH9102 injection) received clinical trial approval in China.
8. China Energy Engineering Corporation (03996.HK): A subsidiary won the EPC general contracting project for the second phase of the Shaanxi Investment Zhaoshipan Power Plant (2×1000MW units), with a winning bid amount of RMB 6.44326 billion.
